Lipotoxicity and insulin resistance;Lipotoxicité et insulinorésistance

Nutrition Clinique et Metabolisme

Volumn 20, Issue 2, 2006, Pages 108-113

  Magnan, Christophe ^a  

^a CNRS   (France)

Author keywords

Acyl CoA; Ceramides; PPARs; Serine threonine kinases

Indexed keywords

CERAMIDE; DIACYLGLYCEROL; FATTY ACID AMIDASE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; PALMITOYL COENZYME A HYDROLASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PROTEIN KINASE C; PROTEIN SERINE KINASE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; DIABETES MELLITUS; GLUCOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGENOLYSIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIVER; METABOLITE; OXIDATION; OXIDATIVE STRESS; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 33745421496     PISSN: 09850562     EISSN: 17683092     Source Type: Journal    
DOI: 10.1016/j.nupar.2006.04.006     Document Type: Article

References (25)

1. Boden G. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 111 (2003) 121-124
2. McGarry J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002) 7-18
3. Boden G., and Shulman G.I. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur. J. Clin. Invest. 32 Suppl 3 (2002) 14-23
4. Kim J.K., Gavrilova O., Chen Y., Reitman M.L., and Shulman G.I. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J. Biol. Chem. 275 (2000) 8456-8460
5. Randle P.J., Garland P.B., Hales C.N., and Newsholme E.A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1 (1963) 785-789
6. Shulman G.I. Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy. Physiology (Bethesda) 19 (2004) 183-190
7. Krebs M., and Roden M. Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Diabetes Obes. Metab. 7 (2005) 621-632
8. Schinner S., Scherbaum W.A., Bornstein S.R., and Barthel A. Molecular mechanisms of insulin resistance. Diabet. Med. 22 (2005) 674-682
9. Kim J.K., Fillmore J.J., Sunshine M.J., Albrecht B., Higashimori T., Kim D.W., et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 114 (2004) 823-827
10. Savage D.B., Petersen K.F., and Shulman G.I. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 45 (2005) 828-833
11. Schernthaner G.H., and Schernthaner G. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention. Scand. J. Clin. Lab. Invest. Suppl. 240 (2005) 30-40
12. Vettor R., Milan G., Rossato M., and Federspil G. Review article: adipocytokines and insulin resistance. Aliment. Pharmacol. Ther. 22 Suppl 2 (2005) 3-10
13. Boden G. Interaction between free fatty acids and glucose metabolism. Curr. Opin. Clin. Nutr. Metab. Care 5 (2002) 545-549
14. Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann. Med. 37 (2005) 347-356
15. Boden G., Cheung P., Stein T.P., Kresge K., and Mozzoli M. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E12-E19
16. Olefsky J.M., and Saltiel A.R. PPARgamma and the treatment of insulin resistance. Trends Endocrinol. Metab. 11 (2000) 362-367
17. Nguyen M.T., Satoh H., Favelyukis S., Babendure J.L., Imamura T., Sbodio J.I., et al. JNK and Tumor Necrosis Factor-{alpha} Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes. J. Biol. Chem. 280 (2005) 35361-35371
18. Engeli S., Bohnke J., Feldpausch M., Gorzelniak K., Heintze U., Janke J., et al. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes. Res. 12 (2004) 9-17
19. Kannisto K., Pietilainen K.H., Ehrenborg E., Rissanen A., Kaprio J., Hamsten A., et al. Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. J. Clin. Endocrinol. Metab. 89 (2004) 4414-4421
20. Beltowski J. Adiponectin and resistin-new hormones of white adipose tissue. Med. Sci. Monit. 9 (2003) RA55-RA61
21. Alzahrani A.S. Resistin: can we resist its role in insulin resistance?. Ann. Saudi Med. 25 (2005) 281-282
22. Faraj M., Lu H.L., and Cianflone K. Diabetes, lipids, and adipocyte secretagogues. Biochem. Cell Biol. 82 (2004) 170-190
23. Bajaj M., Suraamornkul S., Piper P., Hardies L.J., Glass L., Cersosimo E., et al. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J. Clin. Endocrinol. Metab. 89 (2004) 200-206
24. Schneider J.G., von Eynatten M., Schiekofer S., Nawroth P.P., and Dugi K.A. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care 28 (2005) 2181-2186
25. Borst S.E., Conover C.F., and Bagby G.J. Association of resistin with visceral fat and muscle insulin resistance. Cytokine 32 (2005) 39-44